Edwards Lifesciences Corp. Earnings

Edwards Lifesciences Corp.’s revenue fell -9.67% since last year same period to $1385.8Mn in the Q4 2024. On a quarterly growth basis, Edwards Lifesciences Corp. has generated 2.32% jump in its revenue since last 3-months.

Edwards Lifesciences Corp.’s net profit jumped 4.24% since last year same period to $385.6Mn in the Q4 2024. On a quarterly growth basis, Edwards Lifesciences Corp. has generated -87.44% fall in its net profits since last 3-months.

Edwards Lifesciences Corp.’s net profit margin jumped 15.4% since last year same period to 27.83% in the Q4 2024. On a quarterly growth basis, Edwards Lifesciences Corp. has generated -87.73% fall in its net profit margins since last 3-months.

Edwards Lifesciences Corp.’s earning per share (EPS) estimates for the current quarter stand at 0.6 - a 7.39% jump from last quarter’s estimates.

Edwards Lifesciences Corp.’s earning per share (EPS) estimates for the current year stand at 0.6.

Edwards Lifesciences Corp.’s earning per share (EPS) fell -3.03% since last year same period to 0.64 in the Q1 2025. This indicates that the Edwards Lifesciences Corp. has generated -3.03% annual rate of fall in its earning per share (EPS) in the last 4 quarters.